Chimpanzee adenovirus vector, construction method therefor, and application thereof
AssigneeJiaxing Anyu Biotechnology Co., Ltd.
InventorsPing Chen, Na Li, Tingting Zhang, Xintao Zhong, Zhigang Zhu, Nan Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeJiaxing Anyu Biotechnology Co., Ltd.
InventorsPing Chen, Na Li, Tingting Zhang, Xintao Zhong, Zhigang Zhu, Nan Li
Estimating the term…
A chimpanzee adenovirus vector from newly discovered and isolated chimpanzee adenovirus with unique HVR sequences and a method of its construction and application thereof, with higher viral titer, and provides a method for determining its viral titer. The chimpanzee adenovirus circular vector is constructed through a shuttle plasmid, and knocks out E1 and E3 to construct a replication-defective chimpanzee adenovirus vector. The chimpanzee adenovirus vector described in this article has no preexisting antibody in the population, and the knockout of E1 and E3 is safe. At the same time, it is significantly different from human adenovirus type 5 E1 in 293 cells, which can greatly avoid recovery mutation (RCA) and make it safer. The novel coronavirus vaccine has strong stability and does not cause mutations after multiple passages, and it can induce strong humoral immunity and cellular response in mouse models.
A chimpanzee adenovirus having a nucleotide sequence, wherein the chimpanzee adenovirus comprises a conserved region, E1 and E3 genes are deleted in the conserved region, and the nucleotide sequence after deletion is represented by SEQ ID NO. 4.
Dependencies are inferred from the claim text.